GAZYVARO conc perf 1000 mg/40 ml flac

7680631720015 CH-63172 L01FA03 07.16.1.

Reimbursement limitations:

GAZYVARO.03

Lymphome folliculaire non traité précédemment (LF 1L)
GAZYVARO est remboursé pour le traitement des patients …

GAZYVARO conc perf 1000 mg/40 ml flac
GAZYVARO conc perf 1000 mg/40 ml flac
GAZYVARO conc perf 1000 mg/40 ml flac
1 / 3
google

Details

Product number
6317201
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
obinutuzumabum 1000 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 40 ml.

Articles (1)

Gazyvaro 1000 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
24/11/2023
Professional SmPC
Français
24/11/2023
Professional SmPC
Italien
24/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
1000.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 3328.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2014

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
63172
Drug name
Gazyvaro, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01FA03
Authorization status
Z
Dispensation category
A
First authorization
10/06/2014
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
chronische lymphatische Leukämie, follikuläres Lymphom

Packaging details

Description (FR)
GAZYVARO conc perf 1000 mg/40 ml flac
Description (DE)
GAZYVARO Inf Konz 1000 mg/40 ml Durchstf
Market launch
10/06/2014
Narcotic (BTM)
No